In this review:
This publication is intended as an educational resource for healthcare professionals. It discusses
pertussis (whooping cough) infection in individuals with respiratory illnesses such as asthma and
COPD, and outlines the prevention of this disease via immunisation with pertussis-containing vaccines.
Vaccination against pertussis is fully-funded for children and some at-risk individuals in New Zealand as
part of the National Immunisation Schedule. The eligibility criteria for immunisation against pertussis
in New Zealand has expanded. Pharmac has announced that as of 1 July 2020 the diphtheria, tetanus
and pertussis (Tdap) vaccine Boostrix will replace the adult diphtheria and tetanus vaccine (ADT™
Booster) with the current eligibility criteria for Boostrix widened to include eligibility criteria currently in
place for the ADT™ Booster vaccine.
Download PDF